MEPA_R3 Stock Overview
Medical Packaging Company produces and sells glass packaging products for pharmaceutical and medical purposes in Egypt and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Medical Packaging Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م0.15 |
| 52 Week High | ج.م0.24 |
| 52 Week Low | ج.م0.016 |
| Beta | 0.74 |
| 1 Month Change | 73.56% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 297.37% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| MEPA_R3 | EG Packaging | EG Market | |
|---|---|---|---|
| 7D | 0% | -0.6% | -8.4% |
| 1Y | n/a | 357.7% | 52.8% |
Return vs Industry: Insufficient data to determine how MEPA_R3 performed against the EG Packaging industry.
Return vs Market: Insufficient data to determine how MEPA_R3 performed against the EG Market.
Price Volatility
| MEPA_R3 volatility | |
|---|---|
| MEPA_R3 Average Weekly Movement | n/a |
| Packaging Industry Average Movement | 5.1% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in EG Market | 13.3% |
| 10% least volatile stocks in EG Market | 4.8% |
Stable Share Price: MEPA_R3's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine MEPA_R3's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | n/a | Mahir Syed | www.med-pack.com |
Medical Packaging Company produces and sells glass packaging products for pharmaceutical and medical purposes in Egypt and internationally. It offers a range of ampoules, vials, and aluminum caps for use in the packaging of various pharmaceutical liquid products. The company was founded in 2006 and is headquartered in Cairo, Egypt.
Medical Packaging Company Fundamentals Summary
| MEPA_R3 fundamental statistics | |
|---|---|
| Market cap | ج.م133.86m |
| Earnings (TTM) | ج.م8.81m |
| Revenue (TTM) | ج.م53.37m |
15.2x
P/E Ratio2.5x
P/S RatioIs MEPA_R3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEPA_R3 income statement (TTM) | |
|---|---|
| Revenue | ج.م53.37m |
| Cost of Revenue | ج.م36.10m |
| Gross Profit | ج.م17.27m |
| Other Expenses | ج.م8.46m |
| Earnings | ج.م8.81m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.026 |
| Gross Margin | 32.36% |
| Net Profit Margin | 16.50% |
| Debt/Equity Ratio | 12.1% |
How did MEPA_R3 perform over the long term?
See historical performance and comparison